In breast cancer, dihydroartemisinin enhances the radiosensitivity of breast cancer cells by inducing ferroptosis via the hsa_circ_0001610/miR-139-5p/SLC7A11 pathway (Zhang Y. et al., 2024b). Here, SLC7A11 is linked to breast carcinoma.